期刊文献+

2型糖尿病合并视网膜病变患者凝血功能分析 被引量:7

Analysis of coagulation function in type 2 diabetes mellitus patients with diabetic retinopathy
下载PDF
导出
摘要 目的分析2型糖尿病(T2DM)合并视网膜病变(RD)患者的凝血功能。方法选择T2DM确诊患者154例,根据患者眼底检查结果分为无DR(NDR)组、DR组,DR组患者分为增殖性视网膜病变(PDR)组和非PDR(NPDR)组。采集所有患者一般资料,同时检测空腹血糖(FPG)、糖化血红蛋白A1c(HbA1c)、胆固醇(CHOL)、三酰甘油(TG)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)、凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)、纤维蛋白原(FIB)、D-二聚体(DD)、纤维蛋白降解产物(FDP)等指标水平。对各研究组检测结果进行统计学分析。结果各研究组间FPG、HbA1c、CHOL、TG、HDL、LDL、PT、APTT、TT、DD、FDP水平比较差异无统计学意义(P>0.05)。DR组FIB水平高于NDR组(P<0.05),NPDR组、PDR组FIB水平比较差异无统计学意义(P>0.05)。结论糖尿病合并DR患者FIB水平升高,FIB可能在T2DM合并DR的发生、发展过程中起到一定的作用。 Objective To analysis the coagulation function in type 2diabetes mellitus(T2DM)patients with diabetic retinopathy(DR).Methods A total of 154 cases of T2 DM patients were enrolled and divided into non-DR(NDR)group and DR group,which was further divided into proliferative diabetic retinopathy(PDR)group and nonPDR(NPDR)group,according to the results of fundus examination.Clinical data was recorded,and fasting blood glucose(FPG),glycated haemoglobin A1c(HbA1c%),cholesterol(CHOL),triacylglycerol(TG),high density lipoprotein(HDL),low density lipoprotein(LDL),prothrombin time(PT),activated partial thromboplastin time(APTT),thrombin time(TT),fibrinogen(FIB),D-dimer(DD)and fibrin degradation product(FDP)were detected and statistically analyzed.Results There were no statistical differences of FPG,HbA1 c,CHOL,TG,HDL,LDL,PT,APTT,TT,DD and FDP among the three groups(P〉0.05).FIB level in DR group was higher than that in NDR group(P〈0.05),but there was no statistical difference between NPDR group and PDR group(P〉0.05).Conclusion FIB might be a risk factor for the onset of DR.More attention should be paid for the FIB level in T2 DM patients.
出处 《检验医学与临床》 CAS 2015年第7期885-887,共3页 Laboratory Medicine and Clinic
基金 国家高技术研究发展计划(2014AA022304) 首都卫生发展科研专项项目(2011-2008-02)
关键词 2型糖尿病 糖尿病视网膜病变 纤维蛋白原 type 2 diabetic mellitus diabetic retinopathy fibrinogen
  • 相关文献

参考文献21

  • 1Chu L, Fu G,Zhang M, et al. Identification of urinary bio- markers for type 2 diabetes using bead-based proteomic approaeh[J]. Diabetes Res Clin Pract, 2013,101 (2) : 187-193.
  • 2Congdon NG, Fredman DS, Lietman T. Important causes of visual impairment in the world today[J]. JAMA,2003, 290(15) : 2057-2060.
  • 3Saaddine JB, Honeycutt AA, Narayan KM, et al. Projec- tion of diabetic retinopathy and other major eye diseases among people with diabetes mellitus : United States, 2005- 2050[J]. Arch Ophthalmol, 2008,126 (12) : 1740-1747.
  • 4Resnikoff S, Pascolini D, Etyaale D, et al. Global data on visual impairment in the year 2002[J]. Bull World Health Organ, 2004,82 (11) : 844-851.
  • 5Chung SS,Chung SK. Genetic analysis of aldose reductase in diabetic complications[J]. Curt Med Chem, 2003, 10 (15) :1375-1387.
  • 6Hohman TC, Nishimura C,Robison WG Jr. Aldose reduc- tase and polyol in cultured pericytes of human retinal cap- illaries[J]. Exp Eye Res,1989,48(1) :55-60.
  • 7Singh R, Barden A, Mori T, et al. Advanced glycation end- products : a review [ J ]. Diabetologia, 2001, 44 ( 2 ) : 129- 146.
  • 8Kaul K, Hodgkinson A, Tarr JM, et al. Is inflammation a common retinal-renal-nerve pathogenic link in diabetes [J]. Curr Diabetes Rev, 2010,6(5) : 294-303.
  • 9MacKinnon JR, Or Brien C, Swa K, et al. Pulsatile ocular blood flow in untreated diabetic retinopathy [J]. Acta Ophthalmol Scand,1997,75(6) :661-664.
  • 10Kowluru RA,Chan PS. Oxidative stress and diabetic reti- nopathy[J/OL]. Exp Diabetes Res, 2007-04-12[2014-11- 12], http://www, ncbi. nlm. nih. gov/pmc/articles/ PMC1880867/.

二级参考文献16

共引文献22

同被引文献58

引证文献7

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部